| Site Map | Contact Us | Font Size |    |
 |
Print Page | ||||
 |
||||||||
 |
||||||||
Medical Educational Grants
Guidelines
Medical Educational Grants are awarded in support of high quality, independent educational programs and materials, which demonstrate the potential to improve patient care and health outcomes. Each educational grant awarded must adhere to and be compliant with:
- FDA Final Guidance on Industry-Supported Scientific and Educational Activities,
- Office of Inspector General (OIG) Guidelines,
- Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support,
- Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals,
- American Medical Association (AMA) Ethical Guidelines for Gifts to Physicians from Industry, and
- Other relevant guidelines and regulations.
Supported programs must be independent, objective, balanced and scientifically rigorous. Grants cannot be tied, in any way, to past, present, or future prescribing, purchasing or recommending (including formulary recommendations) of any drug.
Celgene will consider grant requests for both accredited and non-accredited continuing education; however, preference will be given to accredited educational programs. Celgene will consider requests to support independent medical education programs and activities in the clinical and therapeutic areas of Oncology and Hematology.
To view information about eligibility, budget guidelines, requirements, deadlines, the application process and contact information please click here NEW.
Applications for ASCO sanctioned satellite symposia and associated web-based enduring program for 2012 will be due on November 28, 2011. Multi-company supported initiatives are preferred in the area of metastatic breast cancer. Applications for other ancillary multi-supported symposia will also be accepted and due on November 28, 2011. Please include the following as part of the title of application: "ASCO 2012 Symposium".
Applications for ONS 2012 satellite symposia and associated web-based enduring program for 2012 will be due at the end of business on Wednesday, January 4, 2012. Multi-company supported initiatives are preferred in the areas of Metastatic Breast Cancer and Lymphoma. Please include the following as part of the title of application: "ONS 2012 Symposium".
Applications for ASH 2012 satellite symposia and associated web-based enduring program for 2012 will be due at the end of business on Wednesday, January 25, 2012. Multi-company supported initiatives are preferred in the areas of Multiple Myeloma and Non-Hodgkin’s Lymphoma. Applications for other multi-supported symposia will also be accepted and due on January 25. Please include the following as part of the title of application: "ASH 2012 Symposium".
Applications for a post Congress activity must be submitted 30 days prior to the start date of the Congress in order to be reviewed by the grant committee (e.g., post ASCO programs must be submitted by May 3, 2011 as ASCO starts on June 3, 2011).
Please note: Grant applications must now be submitted at least 60 days prior to the start date of your program! Applications submitted less than that timeframe will not be considered for review.
First-time Visitors, Register Here.
Registered Users, Log In Here.